A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Safety and Efficacy of OBI-858 in Patients with Moderate-to-Severe Glabellar Lines - Quiz - MDSpire

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Safety and Efficacy of OBI-858 in Patients with Moderate-to-Severe Glabellar Lines

  • By

  • Yu-Hsiu Yen

  • Tzu-Wen Tsau

  • Chih-Hung Lee

  • Hsin-Han Chen

  • Chih-Hung Lin

  • Tim-Mo Chen

  • Chi-Ming Pu

  • November 1, 2025

  • 0 min

Share

Original Source(s)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Safety and Efficacy of OBI-858 in Patients with Moderate-to-Severe Glabellar Lines

  • by Yu-Hsiu Yen, Tzu-Wen Tsau, Chih-Hung Lee, Hsin-Han Chen, Chih-Hung Lin, Tim-Mo Chen, Chi-Ming Pu

  • November 1, 2025

Related Content

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Dry Eye: Adding Aesthetics

This step-by-step process added revenue to the dry eye disease side of my practice.

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice